Associated Papers
A Global Approach to the Long-Term Follow-up of 17 Families with Bilateral Macronodular Adrenal Disease.
Charchar HLS et al.
The Journal of Clinical Endocrinology and Metabolism, 2025
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update.
Bouys L et al.
Orphanet Journal of Rare Diseases, 2025
Unravelling the Genetic Basis of Primary Aldosteronism.
Mourtzi N et al.
Nutrients, 2021
ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.
Maria AG et al.
Endocrine-related Cancer, 2020
Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations.
Sprissler R et al.
Cancers, 2020
32570879 (PubMed )
Supplement: cancers-12-01618-s001.zip › cancers-817200-Supplementary_Materials3 › Supplementary_table_S1.xlsx › TSG
Genetics of primary hyperaldosteronism.
Dutta RK et al.
Endocrine-related Cancer, 2016
iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers.
Wang M et al.
Scientific Reports, 2016
27527004 (PubMed )
Supplement: srep31321-s4.xls › SwissvarFilteredMix
ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions.
Mulatero P et al.
Journal of Human Hypertension, 2016
Primary Aldosteronism and ARMC5 Variants.
Zilbermint M et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.
Espiard S et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation.
Faucz FR et al.
The Journal of Clinical Endocrinology and Metabolism, 2014
Select a paper to view details